Overview
- The outbreak, first declared in mid‑May, has grown into the largest recorded in the Democratic Republic of Congo with several thousand confirmed infections and roughly 1,700–1,800 reported deaths.
- World Health Organization officials and aid groups warn transmission is accelerating across multiple eastern provinces as some areas report case counts doubling and infections spreading outside known chains.
- Early clinical responses have moved fast: medication trials are enrolling patients at treatment centers and Phase‑1 vaccine trials by Moderna and the University of Oxford/Serum Institute of India have started to test safety and immune response.
- Containment is hampered by failing contact tracing, distrust of authorities, active armed conflict, mass displacement and looming rainy‑season transport problems that limit access for response teams.
- The U.S. pledged an additional ~$242 million, raising direct American support to over $500 million, but responders say months and far more trained staff, funds and logistics are needed before new treatments or vaccines can reach most affected communities.